Theralase Technologies Inc. V.TLT

RE:RE:AMAZING COMPOUND

[CancerSlayer]

Eoganacht wrote: Yes! You left out bacteria.

As Dr. Coombs and colleagues noted in the recent Heliyon paper:

".Infectious agents (e.g. bacteria, fungi, parasites, and viruses) remain a major cause of morbidity and mortality and still account for more than 10,000,000 deaths annually....with rising antibiotic resistance, infections by resistant bacteria may account for significantly higher death rates within a few decades."

"TLD-1433 also is effective against Gram-negative E. coli [23], and various Gram-positive bacteria such as S. aureus and MRSA [14] Arenas and colleagues demonstrated that TLD-1433 was effective in killing S. aureus and MRSA at dosages ∼1000-fold lower than methylene blue [14]."

https://www.sciencedirect.com/science/article/abs/pii/S1572100013000859

Tarbaby wrote: Rutherrin is truly an amazing compound..
It can kill cancer using photons or xrays.
It also can boost other treatments such as chemo BCG Immunotherapy plus plus..
It can make a vaccine for blood cancers.
Then it can also kill or disable most viruses.
Did I miss anything.?
Its creators might get a Nobel Prize once all of these are proven.

Thanks for noting that...

Antibiotic resistance is definitely on the rise (primarily due to overuse) & the bad bugs are becoming resistant to various 2nd line treatments, making 3rd line treatments (which sometimes requires injection vs oral route) a last stand against a potentially more serious/invasive infection.

Additionally, Big Pharma's recent disinterest in developing new antibiotic therapies (due to generally small profit margins) only compounds the problem...no pun intended.  Having a relatively inexpensively produced/readily available compound (TLD 1433) ready for testing & one that could be priced higher (due to novelty, prior R&D, unmet need, etc.) should make Pharmas smile & regenerate interest re: additional opportunites that TLD 1433 (& others from our library of compounds) could bring to the infectious disease forefront & helping win the war against superbugs.  This area of interest could be its own subsidiary/company.